Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

NeurogesX, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: OTC Bulletin Board: NGSX


Company Description

NeurogesX, Inc. is a biopharmaceutical company, which is focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs. Its product Qutenza, a synthetic capsaicin-based dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. NeurogesX was founded on May 28, 1998 by Wendye R. Robbins and is headquartered in San Mateo, CA.

Similar to: GW Pharmaceuticals Plc, BioGaia AB, Mast Therapeutics, Inc.

Featured Company


Johnson Matthey Plc

London, LO, GB

Johnson Matthey Plc produces catalysts, precious metals and specialty chemicals. The operations of the company are organized into… Learn more →

You may also be interested in:


Mast Therapeutics, Inc.

San Diego, CA, US

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on developing proprietary product candidates. The Companys… Learn more →

BioGaia AB

Stockholm, SE

BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →

GW Pharmaceuticals Plc

Salisbury, WI, GB

GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →